Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 1 - Propanc Biopharma, Inc. | prop_s1a.htm |
| EX-5.1 - OPINION OF GERSTEN SAVAGE LLP - Propanc Biopharma, Inc. | prop_ex51.htm |
| EX-10.9 - RESEARCH ENGAGEMENT - Propanc Biopharma, Inc. | prop_ex109.htm |
| EX-10.12 - RESEARCH AGREEMENT - Propanc Biopharma, Inc. | prop_ex1012.htm |
| EX-10.10 - LETTER OF APPOINTMENT WITH DR. JULIAN KENYON - Propanc Biopharma, Inc. | prop_ex1010.htm |
| EX-10.11 - LETTER OF APPOINTMENT WITH DR. DOUGLAS MITCHELL - Propanc Biopharma, Inc. | prop_ex1011.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the use of our report dated June 22, 2011, on the financial statements of Propanc Health Group Corporation (A Development Stage Company) for the years ended June 30, 2010 and 2009, and for the period from October 15, 2007 (Inception) through June 30, 2010, included herein on the registration statement of Propanc Health Group Corporation on Form S-1/A Amendment No. 1, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ Salberg & Company, P.A.
SALBERG & COMPANY, P.A.
Boca Raton, Florida
August 18, 2011